Thomas Sciascia
2023
In 2023, Thomas Sciascia earned a total compensation of $977.1K as Chief Scientific Officer at Trevi Therapeutics, a 69% increase compared to previous year.
Compensation breakdown
| Bonus | $117,600 |
|---|---|
| Option Awards | $425,699 |
| Salary | $424,677 |
| Other | $9,149 |
| Total | $977,125 |
Sciascia received $425.7K in option awards, accounting for 44% of the total pay in 2023.
Sciascia also received $117.6K in bonus, $424.7K in salary and $9.1K in other compensation.
Rankings
In 2023, Thomas Sciascia's compensation ranked 1,245th out of 3,006 executives tracked by ExecPay. In other words, Sciascia earned more than 58.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,245 out of 3,006 | 59th |
Division Manufacturing | 737 out of 1,650 | 55th |
Major group Chemicals And Allied Products | 493 out of 918 | 46th |
Industry group Drugs | 481 out of 881 | 45th |
Industry Pharmaceutical Preparations | 332 out of 637 | 48th |
Source: SEC filing on April 26, 2024.
Sciascia's colleagues
We found two more compensation records of executives who worked with Thomas Sciascia at Trevi Therapeutics in 2023.